AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 11,813 shares, a drop of 48.8% from the November 30th total of 23,090 shares. Currently, 0.3% of the company’s shares are sold short. Based on an average daily trading volume, of 22,365 shares, the short-interest ratio is presently 0.5 days. Based on an average daily trading volume, of 22,365 shares, the short-interest ratio is presently 0.5 days. Currently, 0.3% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of AquaBounty Technologies in a report on Monday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, AquaBounty Technologies currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On AquaBounty Technologies

An institutional investor recently bought a new position in AquaBounty Technologies stock. Two Sigma Investments LP purchased a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned approximately 0.97% of AquaBounty Technologies as of its most recent SEC filing. Institutional investors own 8.92% of the company’s stock.

AquaBounty Technologies Stock Performance

Shares of AquaBounty Technologies stock opened at $1.02 on Friday. AquaBounty Technologies has a 52 week low of $0.50 and a 52 week high of $2.95. The stock has a market capitalization of $3.96 million, a price-to-earnings ratio of -1.23 and a beta of 1.36. The firm has a fifty day moving average of $1.07 and a two-hundred day moving average of $1.09.

AquaBounty Technologies (NASDAQ:AQB) last released its earnings results on Tuesday, October 28th. The company reported ($0.36) earnings per share for the quarter, beating the consensus estimate of ($0.62) by $0.26.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.